Infectious complications in renal transplant recipients

被引:15
作者
Tanphaichitr, NT [1 ]
Brennan, DC [1 ]
机构
[1] Washington Univ, Sch Med, Dept Med, Div Renal, St Louis, MO 63110 USA
来源
ADVANCES IN RENAL REPLACEMENT THERAPY | 2000年 / 7卷 / 02期
关键词
infection; transplant; kidney; immunosuppression; cytomegalovirus;
D O I
10.1053/rr.2000.5270
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Infectious complications present major challenges to physicians caring for renal transplant recipients. The high rate of infection reflects the net state of immunosuppression associated with end-stage renal disease, transplantation, donor and environmental exposure. An understanding of the factors that affect the patients' overall state of immunosuppression is essential to prevent and treat infectious complications, which may lead to significant morbidity, graft dysfunction, or mortality. Familiarity with the various pathogens, clinical presentation, diagnostic options, treatment, and prophylaxis is important to care for renal transplant patients. The authors present their approach, based on review of current literature, to these issues. (C) 2000 by the National Kidney Foundation, inc.
引用
收藏
页码:131 / 146
页数:16
相关论文
共 84 条
[1]   NOCARDIOSIS IN RENAL-TRANSPLANT RECIPIENTS UNDERGOING IMMUNOSUPPRESSION WITH CYCLOSPORINE [J].
ARDUINO, RC ;
JOHNSON, PC ;
MIRANDA, AG .
CLINICAL INFECTIOUS DISEASES, 1993, 16 (04) :505-512
[2]   FAILURE OF HIGH-DOSE ORAL ACYCLOVIR WITH OR WITHOUT IMMUNE GLOBULIN TO PREVENT PRIMARY CYTOMEGALOVIRUS DISEASE IN RECIPIENTS OF SOLID-ORGAN TRANSPLANTS [J].
BAILEY, TC ;
ETTINGER, NA ;
STORCH, GA ;
TRULOCK, EP ;
HANTO, DW ;
DUNAGAN, WC ;
JENDRISAK, MD ;
MCCULLOUGH, CS ;
KENZORA, JL ;
POWDERLY, WG .
AMERICAN JOURNAL OF MEDICINE, 1993, 95 (03) :273-278
[3]   A RANDOMIZED, PLACEBO-CONTROLLED TRIAL OF ORAL ACYCLOVIR FOR THE PREVENTION OF CYTOMEGALO-VIRUS DISEASE IN RECIPIENTS OF RENAL-ALLOGRAFTS [J].
BALFOUR, HH ;
CHACE, BA ;
STAPLETON, JT ;
SIMMONS, RL ;
FRYD, DS .
NEW ENGLAND JOURNAL OF MEDICINE, 1989, 320 (21) :1381-1387
[4]  
Borie DC, 1998, INFECT CONT HOSP EP, V19, P355
[5]  
Bottorff M. B., 1997, Clinical Pharmacology and Therapeutics, V61, P224
[6]   Long-term follow-up of hepatitis C virus infection among organ transplant recipients - Implications for policies on organ procurement [J].
Bouthot, BA ;
Murthy, BVR ;
Schmid, CH ;
Levey, AS ;
Pereira, BJG .
TRANSPLANTATION, 1997, 63 (06) :849-853
[7]   Prophylactic oral ganciclovir compared with deferred therapy for control of cytomegalovirus in renal transplant recipients [J].
Brennan, DC ;
Garlock, KA ;
Singer, GG ;
Schnitzler, MA ;
Lippmann, BJ ;
Buller, RS ;
Gaudreault-Keener, M ;
Lowell, JA ;
Shenoy, S ;
Howard, TK ;
Storch, GA .
TRANSPLANTATION, 1997, 64 (12) :1843-1846
[8]  
Brennan DC, 1997, J AM SOC NEPHROL, V8, P118
[9]  
Brennan DC, 1996, ANN INTERN MED, V124, P693, DOI 10.7326/0003-4819-124-7-199604010-00015
[10]  
CHUGH KS, 1992, TRANSPLANT P, V24, P1940